In conclusion, the present findings decipher that EGFR mutations enhance the NSCLC expression of TGF-β, which contributes to the suppression of CD8+ T cell infiltration, proliferation, and cytotoxicity in the TME. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.